Biodistribution of a nonpeptidic fluorescent endothelin a receptor imaging probe

Molecular Imaging

Volumn 8, Issue 1, 2009, Pages 27-34

  Holtke, Carsten ^a   Waldeck, Jens ^b   Kopka, Klaus ^b   Heindel, Walter ^b   Schober, Otmar ^b   Schafers, Michael ^b   Bremer, Christoph ^b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATTENUATION ,; BIODISTRIBUTION; BIOLOGIC BEHAVIOR; ENDOTHELIN; FLUORESCENCE REFLECTANCE IMAGING; FLUORESCENT IMAGING; FLUORESCENT TRACERS; FLUOROCHROME; HIGH AFFINITY; IMAGING PROBE; LIVER TISSUE; MOLECULAR IMAGING; RECEPTOR EXPRESSION; SIGNAL INTENSITIES; SPECIFIC BINDING; TIME POINTS; TISSUE SAMPLES;

FLUORESCENCE; LIVER; PROBES;

MUSCLE;

CARBOCYANINE; CY5.5 CYANINE DYE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; FLUORESCENT DYE;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; CHEMISTRY; DRUG STABILITY; EVALUATION; FEMALE; FLUORESCENCE MICROSCOPY; HEART MUSCLE; LIVER; LUNG; METABOLISM; METHODOLOGY; MOUSE; SYNTHESIS; TIME; TISSUE DISTRIBUTION;

ANIMALS; CARBOCYANINES; DRUG STABILITY; ENDOTHELIN-1; FEMALE; FLUORESCENT DYES; LIVER; LUNG; MICE; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; MYOCARDIUM; RECEPTOR, ENDOTHELIN A; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 66449135380     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2009.00003     Document Type: Article

References (44)

1. Feldstein C, Romero C. Role of endothelins in hypertension. Am J Ther 2007;14:147-53.
2. Giaid A, Yanagisawa M, Langleben D, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993;328:1732-9.
3. Levin ER. Endothelins. N Engl J Med 1995;333:356-63.
4. Perez del Villar C, Garcia Alonso CJ, Feldstein CA, et al. Role of endothelin in the pathogenesis of hypertension. Mayo Clin Proc 2005;80:84-96.
5. Saito Y, Nakao K, Mukoyama M, et al. Increased plasma endothelin level in patients with essential hypertension. N Engl J Med 1990;322:205.
6. Alanen K, Deng DX, Chakrabarti S. Augmented expression of endothelin-1, endothelin-3 and the endothelin-B receptor in breast carcinoma. Histopathology 2000;36:161-7.
7. Ali H, Dashwood M, Dawas K, et al. Endothelin receptor expression in colorectal cancer. J Cardiovasc Pharmacol 2000;36 (5 Suppl 1):S69-71.
8. Bagnato A, Salani D, Di Castro V, et al. Expression ofendothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumor growth. Cancer Res 1999;59:720-7.
9. Grant K, Loizidou M, Taylor I. Endothelin-1: a multifunctional molecule in cancer. Br J Cancer 2003;88:163-6.
10. Nelson J, Bagnato A, Battistini B, et al. The endothelin axis: emerging role in cancer. Nat Rev Cancer 2003;3:110-6.
11. Salani D, Di Castro V, Nicotra MR, et al. Role of endothelin-1 in neovascularization of ovarian carcinoma. Am J Pathol 2000;157: 1537-47.
12. Wulfing P, Diallo R, Kersting C, et al. Expression of endothelin-1, endothelin-A, and endothelin-B receptor in human breast cancer and correlation with long-term follow-up. Clin Cancer Res 2003;9: 4125-31.
13. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994;46:325-415.
14. Lalich M, McNeel DG, Wilding G, et al. Endothelin receptor antagonists in cancer therapy. Cancer Invest 2007;25:785-94.
15. Bremer C, Ntziachristos V, Mahmood U, et al. Progress in optical imaging. Radiologe 2001;41:131-7.
16. Bremer C, Ntziachristos V, Weissleder R. Optical-based molecular imaging: contrast agents and potential medical applications. Eur Radiol 2003;13:231-43.
17. Ntziachristos V, Bremer C, Graves EE, et al. In vivo tomographic imaging of near-infrared fluorescent probes. Mol Imaging 2002;1: 82-8.
18. a)receptor- selective antagonists. J Med Chem 1995;38:1259-63.
19. Doherty AM, Uprichard AC. Discovery and development of an endothelin A receptor-selective antagonist PD 156707. Pharm Biotechnol 1998;11:81-112.
20. Maguire JJ, Kuc RE, Davenport AP. Affinity and selectivity of PD156707, a novel nonpeptide endothelin antagonist, for human ET(A) and ET(B) receptors. J Pharmacol Exp Ther 1997;280: 1102-8.
21. a receptor antagonist. J Pharmacol Exp Ther 1995;273:1410-7.
22. Höltke C, von Wallbrunn A, Kopka K, et al. A fluorescent photoprobe for the imaging of endothelin receptors. Bioconjug Chem 2007;18:685-94.
23. Patt WC, Edmunds JJ, Repine JT, et al. Structure-activity relationships in a series of orally active gamma-hydroxy butenolide endothelin antagonists. J Med Chem 1997;40:1063-74.
24. Mena I, Perry CM, Harkins S, et al. The role of B lymphocytes in coxsackievirus B3 infection. Am J Pathol 1999;155:1205-15.
25. Davenport AP. Distribution of endothelin receptors. In: Huggins JP, Pelton JT, editors. Endothelins in biology and medicine. Boca Raton (FL): CRC Press; 1997. p. 45-68.
26. Levin ER. Endothelins as cardiovascular peptides. Am J Nephrol 1996;16:246-51.
27. 99mTc-radiofolate tracer. Eur J Nucl Med Mol Imaging 2006;33: 1162-70.
28. 64Cu-labeled vascular endothelial growth factor-121 positron emission tomography. Circulation 2008;117:915-22.
29. 18F]-SB209670 and positron emission tomography (microPET). J Cardiovasc Pharmacol 2004;44:S34-8.
30. Hori S, Komatsu Y, Shigemoto R, et al. Distinct tissue distribution and cellular localization of two messenger ribonucleic acids encoding different subtypes of rat endothelin receptors. Endocrinology 1992;130:1885-95.
31. Terada Y, Tomita K, Nonoguchi H, et al. Different localization of two types of endothelin receptor mRNA in microdissected rat nephron segments using reverse transcription and polymerase chain reaction assay. J Clin Invest 1992;90:107-12.
32. b receptors in rats. Biochem Biophys Res Commun 1994;199:1461-5.
33. Bremnes T, Paasche JD, Mehlum A, et al. Regulation and intracellular trafficking pathways of the endothelin receptors. J Biol Chem 2000;275:17596-604.
34. Paasche JD, Attramadal T, Sandberg C, et al. Mechanisms of endothelin receptor subtype-specific targeting to distinct intracel- lular trafficking pathways. J Biol Chem 2001;276:34041-50.
35. Bhowmick N, Narayan P, Puett D. The endothelin subtype A receptor undergoes agonist- and antagonist-mediated inter- nalization in the absence of signaling. Endocrinology 1998;139: 3185-92.
36. Boscoe MJ, Goodwin AT, Amrani M, et al. Endothelins and the lung. Int J Biochem Cell Biol 2000;32:41-62.
37. Henry PJ. Endothelin receptor distribution and function in the airways. Clin Exp Pharmacol Physiol 1999;26:162-7.
38. Michael JR, Markewitz BA. Endothelins and the lung. Am J Respir Crit Care Med 1996;154(3 Pt 1):555-81.
39. 18F-labelled endothelin-1 reveals prevention of binding to cardiac receptors owing to tissue-specific clearance by ET B receptors in vivo. Br J Pharmacol 2005;144:115-22.
40. Ntziachristos V, Ripoll J, Weissleder R. Would near-infrared fluorescence signals propagate through large human organs for clinical studies? Opt Lett 2002;27:333-5.
41. Weissleder R, Ntziachristos V. Shedding light onto live molecular targets. Nat Med 2003;9:123-8.
42. Ntziachristos V, Bremer C, Weissleder R. Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol 2003;13:195-208.
43. Ghosh N, Majumder SK, Gupta PK. Polarized fluorescence spectroscopy of human tissues. Opt Lett 2002;27:2007.
44. Mohanty SK, Ghosh N, Majumder SK, et al. Depolarization of autofluorescence from malignant and normal human breast tissues. Appl Opt 2001;40:1147-54.